Based on available data on the dysregulation of several circulating CXC chemokines in HCC [15,16], we first hypothesized that serum levels of CXCL1, CXCL10 and CXCL13 might also be altered in patients with BTC. This evidence concerns the gene CXCL1 and hepatocellular carcinoma.